Skip to content

Clinical evaluation of intervention techniques for abnormal glucose tolerance

Clinical evaluation of intervention techniques for abnormal glucose tolerance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040574
Enrollment
Unknown
Registered
2020-12-03
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abnormal glucose tolerance

Interventions

Experimental group:traditional Chinese medicine + auricular-plaster therapy
placebo group:placebo

Sponsors

Eye Hospital of Chinese Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged >=18 years old; (2) Oral glucose tolerance test (INTRAVENOUS plasma glucose): Fasting blood glucose was found in the following two conditions: blood glucose <7.0mmol/L, blood glucose 2 hours after meal: 2h OGTT blood glucose 7.8 mmol/L to 11.1mmol/L; (3) Blood glucose was not controlled by western medicine, Chinese medicine or acupuncture (or the treatment was stopped for 2 weeks); (4) Willing to be randomly assigned to the active and passive intervention technology group and the control group; (5) Can accept auricular point pressure pill treatment; (6) To understand and follow the treatment procedure of auricular point pressing pill; (7) Participate in the experiment voluntarily and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) those who have been diagnosed with diabetes; (2) Women during pregnancy or lactation; (3) those taking benzodiazepines, antipsychotic drugs and receiving corticosteroids or other immunosuppressive drugs; (4) Patients with severe primary diseases such as heart, brain and hematopoietic system, severe liver and kidney damage, malignant tumor, pulmonary infection and other diseases that may affect this study; (5) Patients with ear ulcers, definite ear diseases and skin allergy to adhesive tapes; (6) Ear acupoint pressure pill treatment has been carried out in the past 3 months; (7) Patients with abnormal cognitive function and unable to communicate; (8) the doctor does not consider it appropriate to participate in the clinical trial; (9) Currently participating in other drugs or external therapy clinical trials.

Design outcomes

Primary

MeasureTime frame
The levels of blood glucose;

Secondary

MeasureTime frame
TG;TC;

Countries

China

Contacts

Public ContactJING Lu

Eye Hospital of Chinese Academy of Chinese Medical Sciences

jinglu00@sina.cn+86 136111351223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026